Lezack Adam sold BBNX
October 31, 2025 · Form 4 insider transaction
Lezack Adam sold 1,368 shares of Beta Bionics, Inc. at $26.85 per share, a transaction worth $36.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,368
Price
$26.85
Total value
$36.7K
InsiderLezack Adam
RoleDirector
CompanyBeta Bionics, Inc. (BBNX)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateOctober 31, 2025
Filing dateNovember 5, 2025
Shares owned after9,879
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on July 31, 2025.; The weighted average sale price for the transaction reported was $26.8474 and the range of prices were between $26.27 and $27.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.